Waldenström's Macroglobulinemia (WM)
Also known as: Waldenstrom's Macroglobulinemia / Waldenstrom Macroglobulinemia / Waldenström Macroglobulinemia / Waldenström Macroglobulinaemia / Waldenström's Macroglobulinemia / Lymphoplasmacytoid Lymphoma / Waldenstrom Macroglobulinaemia / Waldenstrom Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia / Waldenstrom's Macroglobulinemia (WM) / Waldenstrom's Disease / Waldenström Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma / Primary macroglobulinaemia / Primary macroglobulinemia / Macroglobulinemia (disorder) / Macroglobulinemia / Waldenstrom's macroglobulinaemias / Waldenstrom's macroglobulinemia NOS / Waldenstrom's macroglobulinaemia NOS / Waldenstrom's macroglobulinaemia / Von Waldenstrom macroglobulinaemia / Von Waldenstrom macroglobulinemia / Macroglobulinaemia NOS / Macroglobulinaemia / Waldenstrom's macroglobulinemia (morphologic abnormality) / Waldenstrom's macroglobulinemia (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06769 | Bendamustine | An antineoplastic agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed following rituximab therapy. |
DB00291 | Chlorambucil | A chemotherapy agent used in the management of chronic lymphocytic leukemia and malignant lymphomas. |
DB00997 | Doxorubicin | A medication used to treat various cancers, including AIDS-associated Kaposi's Sarcoma and metastatic cancers. |
DB09053 | Ibrutinib | An antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia. |
DB01041 | Thalidomide | A medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum. |
DB15035 | Zanubrutinib | A kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy. |